Furthermore, a genome-wide methylation study revealed a cluster of differential methylation probes in the chromosomal region chr.17q21.31, which includes MAPT, the major risk gene for PSP [53] (for review see Debnath et al. [54]). This evidence concerns the gene MAPT and supranuclear palsy, progressive, 1.